- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
18
Stocks where the price continues to rise after more than a year of consistent gains.
18 companies
IQVIA Holdings
Market Cap: US$35.6b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$242.94
7D
20.5%
1Y
24.9%
Kiniksa Pharmaceuticals International
Market Cap: US$6.1b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$79.44
7D
27.2%
1Y
164.3%
Forte Biosciences
Market Cap: US$1.9b
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$76.65
7D
51.1%
1Y
619.0%
iX Biopharma
Market Cap: S$560.9m
A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.
42C
S$0.52
7D
30.0%
1Y
2,636.8%
GlaxoSmithKlineE
Market Cap: ج.م13.9b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م166.50
7D
50.4%
1Y
279.4%
AFT Pharmaceuticals
Market Cap: NZ$469.8m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$4.82
7D
21.1%
1Y
76.6%
Entera Bio
Market Cap: US$193.2m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$3.26
7D
66.3%
1Y
61.4%
Pyxis Oncology
Market Cap: US$184.4m
A clinical stage company, engages in the development of therapeutics to treat solid tumors.
PYXS
US$2.91
7D
30.5%
1Y
155.3%
Vitrafy Life Sciences
Market Cap: AU$235.5m
Engages in the research, development, and commercialization of cryopreservation solutions in Australia.
VFY
AU$3.50
7D
24.6%
1Y
113.4%
Intravenous Infusions
Market Cap: GH₵197.6m
A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.
IIL
GH₵0.79
7D
58.0%
1Y
1,875.0%
International Stem Cell
Market Cap: US$2.1m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.29
7D
66.9%
1Y
96.3%
1933 Industries
Market Cap: CA$2.6m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.01
7D
100.0%
1Y
0%
Rimrock Gold
Market Cap: US$865.2k
Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.
RMRK
US$0.0003
7D
33.3%
1Y
0%
Bright Green
Market Cap: US$133.8k
Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.
BGXX.Q
US$0.0015
7D
87.5%
1Y
149,900.0%
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%
Statera Biopharma
Market Cap: US$14.5k
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.
STAB
US$0.0002
7D
100.0%
1Y
100.0%
ObsEva
Market Cap: US$11.7k
A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.
OBSE.F
US$0.0001
7D
9,900.0%
1Y
0%
eFFECTOR Therapeutics
Market Cap: US$3.8k
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.
EFTR
US$0.0008
7D
300.0%
1Y
300.0%